Anticipate generic drug launch
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Peritoneal dialysis solution containing carbohydrate polymers|
|Abstract:||A peritoneal dialysis solution which comprises a water solution of physiological pH, and having physiological salts and metabolizable carbohydrate polymers in concentrations sufficient to safely effect the removal of solutes and water from a patient by peritoneal dialysis.|
|Inventor(s):||Alexander; Steven R. (Tigard, OR), Myers; W. Michael (Tualatin, OR)|
|Assignee:||Baxter Travenol Laboratories, Inc. (Deerfield, IL)|
1. A method of performing peritoneal dialysis comprising the steps of
(a) introducing into the peritoneal cavity of a patient a solution containing physiological salts in concentrations sufficient to effect the removal of solutes by diffusion from the patient's blood across the peritoneal membrane into the solution, and
(b) reducing the rate of decrease of osmotic pressure with respect to time sufficient to maintain a desired rate of ultrafiltration, by introducing in the solution nonionic starch hydrolyzate glucose polymers in concentrations sufficient to create an osmotic pressure to effect the removal of water by diffusion from the patient's blood across the peritoneal membrane into the solution, the nonionic hydrolyzate glucose polymers having an average degree of polymerization of at least 4 to sustain the osmotic pressure over time due to the relatively slow removal of the polymers by diffusion from the solution across the peritoneal membrane into the patient's blood, when compared to the removal of glucose polymers having an average degree of polymerization less than 4.
2. A method of performing peritoneal dialysis according to claim 1 and further including in said step (b) the introduction of glucose in combination with the nonionic starch hydrolyzate glucose polymers.
3. A method of performing peritoneal dialysis according to claim 1 or 2 wherein, in said step (b), the concentration of the nonionic starch hydrolyzate glucose polymers is sufficient to create an osmolarity of about 272 to about 700 milliosmols per liter of the solution.
4. A method of performing peritoneal dialysis according to claim 3, wherein, in said step (b), the osmolarity created is about 279 to about 480 milliosmols per liter of the solution.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.